Morphine Drugs Market Size, Share, Trends, Growth Outlook

Morphine Drugs Market is estimated to increase at a growth rate of 5.8% CAGR over the forecast period from 2024 to 2032.

The Morphine Drugs Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Immediate Release/ Short Acting Opioids (Codeine, Oxycodone, Hydrocodone, Fentanyl, Morphine, Hydroxymorphone, Oxymorphone, Propoxyphene, Others), Extended Release/Long Acting Opioids (Oxycodone, Hydrocodone, Methadone, Fentanyl, Morphine, Oxymorphone, Tapentadol, Buprenorphine, Hydromorphone, Others)), By Application (Pain Relief (Cancer Pain, Post-Operative Care, Lower Back Pain, Orthopedic, Neuropathic, Fibromyalgia), Anesthesia, Cough Suppression, Diarrhoea Suppression, De-addiction).
 

An Introduction to Morphine Drugs Market in 2024

The Morphine Drugs Market in 2024 is poised for significant growth, driven by the rising prevalence of chronic pain conditions and the increasing demand for effective pain management solutions. Morphine, a potent opioid analgesic, remains a cornerstone in pain management, particularly for severe pain associated with cancer, surgery, and trauma. With advancements in drug delivery systems and formulations, including extended-release formulations and combination therapies, the Morphine Drugs Market offers enhanced efficacy and patient convenience. However, regulatory scrutiny and concerns surrounding opioid abuse and addiction continue to shape the market landscape, prompting pharmaceutical companies to focus on developing abuse-deterrent formulations and alternative pain management strategies.

Morphine Drugs Market Dynamics

Morphine Drugs Market Trend: Rising Demand for Palliative Care Services Driving Morphine Drugs Market Growth

A prominent trend in the Morphine Drugs Market is the increasing demand for palliative care services, which is driving the growth of morphine-based medications. As the global population ages and the prevalence of chronic illnesses such as cancer and terminal diseases rises, there is a growing need for effective pain management solutions. Morphine, being a potent opioid analgesic, is widely used to alleviate moderate to severe pain in patients with advanced diseases, fueling the expansion of the market.

Morphine Drugs Market Driver: Growing Awareness and Acceptance of Opioid Analgesics for Pain Management

The key driver for the Morphine Drugs Market is the growing awareness and acceptance of opioid analgesics, including morphine, for pain management purposes. Healthcare professionals and patients are increasingly recognizing the efficacy of morphine in providing relief from acute and chronic pain conditions. Moreover, efforts to address misconceptions and stigma surrounding opioid use, coupled with improved prescribing practices and regulations, are contributing to the market's growth trajectory.

Morphine Drugs Market Opportunity: Expansion of Morphine Use in Non-Oncological Pain Management

An opportunity within the Morphine Drugs Market lies in the expansion of morphine use beyond oncological pain management to non-oncological pain conditions. While morphine is commonly associated with cancer-related pain, there is a growing body of evidence supporting its efficacy in managing other types of severe pain, such as postoperative pain, neuropathic pain, and traumatic injuries. Manufacturers and healthcare providers can capitalize on this opportunity by exploring new indications for morphine and expanding its accessibility to a broader patient population, thus unlocking untapped market potential.
 

Morphine Drugs Market Segmentation

By Product
Immediate Release/ Short Acting Opioids
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended Release/Long Acting Opioids
-Oxycodone
-Hydrocodone
-Methadone
-Fentanyl
-Morphine
-Oxymorphone
-Tapentadol
-Buprenorphine
-Hydromorphone
-Others

By Application
Pain Relief
-Cancer Pain
-Post-Operative Care
-Lower Back Pain
-Orthopedic
-Neuropathic
-Fibromyalgia
Anesthesia
Cough Suppression
Diarrhoea Suppression
De-addiction

Geographical Analysis

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
• Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
• South America (Brazil, Argentina, Rest of South America)
• Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Morphine Drugs Market Companies

• Pfizer Inc
• Sun Pharmaceutical Industries Ltd
• Verve Health Care Ltd
• Mallinckrodt Pharmaceuticals
• Purdue Pharma
• Qinghai Pharmaceuticals
• AbbVie Inc

*List not exhaustive

Reasons to Buy the Morphine Drugs Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Morphine Drugs Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Morphine Drugs Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Morphine Drugs Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Morphine Drugs Market Size Outlook, $ Million, 2021 to 2030
3.2 Morphine Drugs Market Outlook by Type, $ Million, 2021 to 2030
3.3 Morphine Drugs Market Outlook by Product, $ Million, 2021 to 2030
3.4 Morphine Drugs Market Outlook by Application, $ Million, 2021 to 2030
3.5 Morphine Drugs Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Morphine Drugs Market Industry
4.2 Key Market Trends in Morphine Drugs Market Industry
4.3 Potential Opportunities in Morphine Drugs Market Industry
4.4 Key Challenges in Morphine Drugs Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Morphine Drugs Market Share by Company
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Morphine Drugs Market Outlook By Segments
7.1 Morphine Drugs Market Outlook by Segments
By Product
Immediate Release/ Short Acting Opioids
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended Release/Long Acting Opioids
-Oxycodone
-Hydrocodone
-Methadone
-Fentanyl
-Morphine
-Oxymorphone
-Tapentadol
-Buprenorphine
-Hydromorphone
-Others

By Application
Pain Relief
-Cancer Pain
-Post-Operative Care
-Lower Back Pain
-Orthopedic
-Neuropathic
-Fibromyalgia
Anesthesia
Cough Suppression
Diarrhoea Suppression
De-addiction

8 North America Morphine Drugs Market Analysis And Outlook To 2030
8.1 Introduction to North America Morphine Drugs Markets in 2024
8.2 North America Morphine Drugs Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Morphine Drugs Market size Outlook by Segments, 2021-2030
By Product
Immediate Release/ Short Acting Opioids
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended Release/Long Acting Opioids
-Oxycodone
-Hydrocodone
-Methadone
-Fentanyl
-Morphine
-Oxymorphone
-Tapentadol
-Buprenorphine
-Hydromorphone
-Others

By Application
Pain Relief
-Cancer Pain
-Post-Operative Care
-Lower Back Pain
-Orthopedic
-Neuropathic
-Fibromyalgia
Anesthesia
Cough Suppression
Diarrhoea Suppression
De-addiction

9 Europe Morphine Drugs Market Analysis And Outlook To 2030
9.1 Introduction to Europe Morphine Drugs Markets in 2024
9.2 Europe Morphine Drugs Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Morphine Drugs Market Size Outlook By Segments, 2021-2030
By Product
Immediate Release/ Short Acting Opioids
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended Release/Long Acting Opioids
-Oxycodone
-Hydrocodone
-Methadone
-Fentanyl
-Morphine
-Oxymorphone
-Tapentadol
-Buprenorphine
-Hydromorphone
-Others

By Application
Pain Relief
-Cancer Pain
-Post-Operative Care
-Lower Back Pain
-Orthopedic
-Neuropathic
-Fibromyalgia
Anesthesia
Cough Suppression
Diarrhoea Suppression
De-addiction

10 Asia Pacific Morphine Drugs Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Morphine Drugs Markets in 2024
10.2 Asia Pacific Morphine Drugs Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Morphine Drugs Market size Outlook by Segments, 2021-2030
By Product
Immediate Release/ Short Acting Opioids
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended Release/Long Acting Opioids
-Oxycodone
-Hydrocodone
-Methadone
-Fentanyl
-Morphine
-Oxymorphone
-Tapentadol
-Buprenorphine
-Hydromorphone
-Others

By Application
Pain Relief
-Cancer Pain
-Post-Operative Care
-Lower Back Pain
-Orthopedic
-Neuropathic
-Fibromyalgia
Anesthesia
Cough Suppression
Diarrhoea Suppression
De-addiction

11 South America Morphine Drugs Market Analysis And Outlook To 2030
11.1 Introduction to South America Morphine Drugs Markets in 2024
11.2 South America Morphine Drugs Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Morphine Drugs Market size Outlook by Segments, 2021-2030
By Product
Immediate Release/ Short Acting Opioids
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended Release/Long Acting Opioids
-Oxycodone
-Hydrocodone
-Methadone
-Fentanyl
-Morphine
-Oxymorphone
-Tapentadol
-Buprenorphine
-Hydromorphone
-Others

By Application
Pain Relief
-Cancer Pain
-Post-Operative Care
-Lower Back Pain
-Orthopedic
-Neuropathic
-Fibromyalgia
Anesthesia
Cough Suppression
Diarrhoea Suppression
De-addiction

12 Middle East And Africa Morphine Drugs Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Morphine Drugs Markets in 2024
12.2 Middle East and Africa Morphine Drugs Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Morphine Drugs Market size Outlook by Segments, 2021-2030
By Product
Immediate Release/ Short Acting Opioids
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended Release/Long Acting Opioids
-Oxycodone
-Hydrocodone
-Methadone
-Fentanyl
-Morphine
-Oxymorphone
-Tapentadol
-Buprenorphine
-Hydromorphone
-Others

By Application
Pain Relief
-Cancer Pain
-Post-Operative Care
-Lower Back Pain
-Orthopedic
-Neuropathic
-Fibromyalgia
Anesthesia
Cough Suppression
Diarrhoea Suppression
De-addiction

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Pfizer Inc
Sun Pharmaceutical Industries Ltd
Verve Health Care Ltd
Mallinckrodt Pharmaceuticals
Purdue Pharma
Qinghai Pharmaceuticals
AbbVie Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

Morphine Drugs Market Segmentation

By Product
Immediate Release/ Short Acting Opioids
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended Release/Long Acting Opioids
-Oxycodone
-Hydrocodone
-Methadone
-Fentanyl
-Morphine
-Oxymorphone
-Tapentadol
-Buprenorphine
-Hydromorphone
-Others

By Application
Pain Relief
-Cancer Pain
-Post-Operative Care
-Lower Back Pain
-Orthopedic
-Neuropathic
-Fibromyalgia
Anesthesia
Cough Suppression
Diarrhoea Suppression
De-addiction

Geographical Analysis

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
• Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
• South America (Brazil, Argentina, Rest of South America)
• Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)